Variant report
| Variant | nsv466190 |
|---|---|
| Chromosome Location | chr9:11709025-11817216 |
| allele | n/a |
| Outlinks | Ensembl UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No data |
| No data |
| No data |
(count:1 , 50 per page) page:
1
| No. | lncRNA name | Chromosome Location | lncRNA alias |
|---|---|---|---|
| 1 | lnc-PTPRD-10 | chr9:11816029-11816601 | l_3733_chr9:11816028-11824988_testes |
| No data |
| No data |
| No data |
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs371312448 | chr9:11728621-11728622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 2 | rs576708454 | chr9:11728624-11728625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 3 | rs564305781 | chr9:11728628-11728629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 4 | rs533192297 | chr9:11728636-11728637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 5 | rs549888118 | chr9:11728654-11728655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 6 | rs372804498 | chr9:11728672-11728673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 7 | rs569731331 | chr9:11728677-11728678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 8 | rs180797137 | chr9:11728714-11728715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 9 | rs566463508 | chr9:11728723-11728724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 10 | rs536146967 | chr9:11728750-11728751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 11 | rs377250630 | chr9:11728754-11728755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 12 | rs7024387 | chr9:11728789-11728790 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 13 | rs185201675 | chr9:11728796-11728797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 14 | rs572618667 | chr9:11728809-11728810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 15 | rs12350169 | chr9:11728848-11728849 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 16 | rs577792744 | chr9:11728852-11728853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 17 | rs3926216 | chr9:11728856-11728857 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 18 | rs190307062 | chr9:11728859-11728860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 19 | rs181108519 | chr9:11728911-11728912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 20 | rs79515654 | chr9:11728929-11728930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 21 | rs542723111 | chr9:11728930-11728931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 22 | rs186097548 | chr9:11728931-11728932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 23 | rs573205215 | chr9:11728936-11728937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 24 | rs191819700 | chr9:11728942-11728943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 25 | rs564259525 | chr9:11728947-11728948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 26 | rs533283179 | chr9:11728949-11728950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 27 | rs12350218 | chr9:11728990-11728991 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 28 | rs184045367 | chr9:11729004-11729005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 29 | rs188975976 | chr9:11729019-11729020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 30 | rs73405330 | chr9:11729025-11729026 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 31 | rs115061802 | chr9:11729039-11729040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 32 | rs139050787 | chr9:11729048-11729049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 33 | rs145270258 | chr9:11729049-11729050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 34 | rs552034585 | chr9:11729083-11729084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 35 | rs10960131 | chr9:11729084-11729085 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 36 | rs537352294 | chr9:11729091-11729092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 37 | rs370932061 | chr9:11729117-11729118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 38 | rs535839583 | chr9:11729119-11729120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 39 | rs557093234 | chr9:11729122-11729123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 40 | rs191877092 | chr9:11729135-11729136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 41 | rs114289945 | chr9:11729139-11729140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 42 | rs118079540 | chr9:11729146-11729147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 43 | rs201893070 | chr9:11729156-11729157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 44 | rs545041434 | chr9:11729181-11729182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 45 | rs1486804 | chr9:11729182-11729183 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 46 | rs182924607 | chr9:11729204-11729205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 47 | rs144990876 | chr9:11729231-11729232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 48 | rs368315134 | chr9:11729248-11729249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 49 | rs73405332 | chr9:11729275-11729276 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 50 | rs186496053 | chr9:11729289-11729290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Variant related diseases (count:104)
| Disease | PMID | Source |
|---|---|---|
| Disorders of sex development | 21048976 | CNVD |
| Honadal dysgenesis | 21048976 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Lung cancer | 16740712 | CNVD |
| Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
| Basal cell lymphoma | 17170743 | CNVD |
| Follicular lymphoma | 17170743 | CNVD |
| Oral squamous cell carcinoma | 17134496 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| abnormal development | 18461090 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Breast cancer | 16608533 | CNVD |
| Hodgkin''s lymphoma | 18641027 | CNVD |
| Acute lymphoblastic leukemia | 20067559 | CNVD |
| Breast cancer | 16272173 | CNVD |
| Hepatocellular carcinoma | 16750200 | CNVD |
| Breast cancer | 17133270 | CNVD |
| Endometrioid adenocarcinoma | 16974079 | CNVD |
| Cervical cancer | 21063398 | CNVD |
| Retinoblastoma | 22278416 | CNVD |
| Splenic marginal zone lymphoma | 18492102 | CNVD |
| Melanoma | 18172304 | CNVD |
| Biliary cancer | 19435499 | CNVD |
| Gastric cancer | 21586687 | CNVD |
| Esophageal squamous carcinoma | 18350619 | CNVD |
| Myopathy | 18421352 | CNVD |
| Neuroblastoma | 18664255 | CNVD |
| Acute lymphoblastic leukemia | 18957548 | CNVD |
| Myeloproliferative neoplasm | 17564968 | CNVD |
| Malignant meningioma | 17937814 | CNVD |
| Glioma | 21971842 | CNVD |
| Esophageal squamous carcinoma | 21637470 | CNVD |
| Ewing''s sarcoma | 21437220 | CNVD |
| Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
| Astrocytoma | 17387387 | CNVD |
| Breast cancer | 17603634 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Glioblastoma multiforme | 19960244 | CNVD |
| Glioblastoma multiforme | 17387387 | CNVD |
| Hepatocellular carcinoma | 22174799 | CNVD |
| Oligodendroglial tumors | 17285580 | CNVD |
| Cutaneous squamous cell carcinomas | 19131950 | CNVD |
| Small bowel adenocarcinoma | 21586687 | CNVD |
| Basal cell lymphoma | 16317097 | CNVD |
| Diffuse large b-cell lymphoma | 16317097 | CNVD |
| Chordoma | 18071362 | CNVD |
| Acute lymphoblastic leukemia | 22237106 | CNVD |
| Chordoma | 21602918 | CNVD |
| Renal cell carcinoma | 18592004 | CNVD |
| Developmental delay | 19490664 | CNVD |
| Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
| microdeletion syndrome | 16199537 | CNVD |
| Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
| Cancer | 20164919 | CNVD |
| Chronic myeloid leukemia | 21384125 | CNVD |
| Ovarian cancer | 21720365 | CNVD |
| Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Lung cancer | 18438408 | CNVD |
| Urothelial carcinoma | 21177765 | CNVD |
| Oral cancer | 21386901 | CNVD |
| lymphocytic leukemia | 21291569 | CNVD |
| Acute lymphoblastic leukemia | 21339820 | CNVD |
| Intellectual disability | 22102821 | CNVD |
| Breast cancer | 21785460 | CNVD |
| Esophageal adenocarcinoma | 19417022 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| Breast cancer | 21858162 | CNVD |
| Renal cell carcinoma | 21668985 | CNVD |
| Myelodysplastic syndrome | 21251322 | CNVD |
| Autism | 22495311 | CNVD |
| Hepatocellular carcinoma | 18803288 | CNVD |
| Breast cancer | 21364760 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Glioblastoma | 19074898 | CNVD |
| Malignant melanoma | 19074898 | CNVD |
| Prostate cancer | 16573809 | CNVD |
| Metanephric adenoma | 20802469 | CNVD |
| Cancer | 20164920 | CNVD |
| Developmental delay | 21147756 | CNVD |
| small cell lung cancer | 21764851 | CNVD |
| Glioblastoma multiforme | 22286061 | CNVD |
| Glioma | 17123091 | CNVD |
| Lung cancer | 16773561 | CNVD |
| Colorectal cancer | 16272173 | CNVD |
| Esophageal squamous carcinoma | 18405350 | CNVD |
| Gastric cancer | 16891809 | CNVD |
| Mental retardation | 17847001 | CNVD |
| Cutaneous squamous cell carcinomas | 17420988 | CNVD |
| Acute lymphoblastic leukemia | 21390130 | CNVD |
| Pilocytic astrocytoma | 18670637 | CNVD |
| Acute lymphoblastic leukemia | 17690704 | CNVD |
| Acute myeloid leukemia | 21251322 | CNVD |
| Breast cancer | 21611746 | CNVD |
| Melanoma | 22183965 | CNVD |
| Barrett''s syndrome | 19417022 | CNVD |
| low-grade B-cell lymphoma tumor | 18367492 | CNVD |
| Schizophrenia | 18511947 | CNVD |
| Schizophrenia | 23813976 | CNVD |
| Type 2 diabetes | 21526130 | CNVD |
| Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr9:11728600-11729400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
| 2 | chr9:11728800-11729200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
| 3 | chr9:11729000-11729400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
| 4 | chr9:11743000-11743800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
| 5 | chr9:11748800-11750000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
| 6 | chr9:11775800-11776400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
| 7 | chr9:11779600-11780800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
| 8 | chr9:11788400-11788600 | Enhancers | Pancreas | Pancrea |
| 9 | chr9:11795000-11795400 | Bivalent Enhancer | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
| 10 | chr9:11806000-11806600 | Enhancers | Fetal Heart | heart |
| 11 | chr9:11812600-11813000 | Enhancers | Fetal Brain Male | brain |
